Serum metabolic fingerprinting of psoriasis and psoriatic arthritis patients using solid-phase microextraction—liquid chromatography—high-resolution mass spectrometry
Tóm tắt
Psoriatic arthritis (PsA), an inflammatory arthritis that develops in individuals with psoriasis, is associated with reduced quality of life. Identifying biomarkers associated with development of PsA as well as with PsA disease activity may help management of psoriatic disease. To use metabolomic fingerprinting to determine potential candidate markers of disease conversion (psoriasis to PsA) and/or PsA activity. A novel sample preparation protocol based on solid-phase microextraction (SPME) was used to prepare serum samples obtained from: (1) individuals with psoriasis, some of whom develop psoriatic arthritis (n = 20); (2) individuals with varying PsA activity (mild, moderate, severe; n = 10 each) and (3) healthy controls (n = 10). Metabolomic fingerprinting of the obtained extracts was performed using reversed-phase liquid chromatography coupled to high resolution mass spectrometry. Psoriasis patients who developed PsA had similar metabolomic profiles to patients with mild PsA and were also indistinguishable from patients with psoriasis who did not develop PsA. Elevated levels of selected long-chain fatty acids (e.g., 3-hydroxytetradecanedioic acid) that are associated with dysregulation of fatty acid metabolism, were observed in patients with severe PsA. In addition, 1,11-undecanedicarboxylic acid—an unusual fatty acid associated with peroxisomal disorders—was also identified as a classifier in PsA patients vs. healthy individuals. Furthermore, a number of different eicosanoids with either pro- or anti-inflammatory properties were detected solely in serum samples of patients with moderate and severe PsA. A global metabolomics approach was employed to analyze the serum metabolome of patients with psoriasis, PsA, and healthy controls in order to examine potential differences in the biochemical profiles at a metabolite level. A closer examination of circulating metabolites may potentially provide markers of PsA activity.
Tài liệu tham khảo
Abji, F., Pollock, R. A., Liang, K., Chandran, V., & Gladman, D. D. (2016). Brief Report: CXCL10 Is a Possible Biomarker for the Development of Psoriatic Arthritis Among Patients With Psoriasis. Arthritis & Rheumatology, 68(12), 2911–2916. https://doi.org/10.1002/art.39800
Alinaghi, F., Calov, M., Kristensen, L. E., Gladman, D. D., Coates, L. C., Jullien, D., Gottlieb, A. B., Gisondi, P., Wu, J. J., Thyssen, J. P., & Egeberg, A. (2019). Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2018.06.027
Armstrong, A. W., Wu, J., Johnson, M. A., Grapov, D., Azizi, B., Dhillon, J., & Fiehn, O. (2014). Metabolomics in psoriatic disease: pilot study reveals metabolite differences in psoriasis and psoriatic arthritis. Research. https://doi.org/10.12688/f1000research.4709.1
Bergoffen, J., Kaplan, P., Hale, D. E., Bennett, M. J., & Berry, G. T. (1993). Marked elevation of urinary 3-hydroxydecanedioic acid in a malnourished infant with glycogen storage disease, mimicking long-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency. Journal of Inherited Metabolic Disease, 16(5), 851–856. https://doi.org/10.1007/bf00714277
Birjandi, A. P., Bojko, B., Ning, Z., Figeys, D., & Pawliszyn, J. (2017). High throughput solid phase microextraction: A new alternative for analysis of cellular lipidome? Journal of Chromatography b: Analytical Technologies in the Biomedical and Life Sciences, 1043, 12–19. https://doi.org/10.1016/j.jchromb.2016.09.034
Bojko, B., Reyes-Garcés, N., Bessonneau, V., Goryński, K., Mousavi, F., Souza Silva, E. A., & Pawliszyn, J. (2014). Solid-phase microextraction in metabolomics. TrAC Trends in Analytical Chemistry, 61, 168–180. https://doi.org/10.1016/j.trac.2014.07.005
Chandran, V., Gottlieb, A., Cook, R. J., Duffin, K. C., Garg, A., Helliwell, P., Kavanaugh, Arthur, Krueger, G. G., Langley, R. G., Lynde, Charles, McHugh, Neil, Mease, Philip, Olivieri, Ignazio, Rahman, Proton, Rosen, C. F., Salvarani, Carlo, Thaci, Diamant, Toloza, S. M. A., Wong, M. Y. W.,...Gladman, D. D. (2009). International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis & Rheumatism, 61(9), 1235–1242. https://doi.org/10.1002/art.24562
Coras, R., Kavanaugh, A., Boyd, T., Huynh, Q., Pedersen, B., Armando, A. M., Dahlberg-Wright, Signe, Marsal, Sara, Jain, Mohit, Paravar, Taraneh, Quehenberger, Oswald, & Guma, Monica. (2019). Pro- and anti-inflammatory eicosanoids in psoriatic arthritis. Metabolomics. https://doi.org/10.1007/s11306-019-1527-0
Duarte-García, A., Leung, Y. Y., Coates, L. C., Beaton, D., Christensen, R., Craig, E. T., de Wit, M., Eder, Lihi, Fallon, Lara, FitzGerald, Oliver, Gladman, D. D., Goel, Niti, Holland, Richard, Lindsay, Chris, Maxwell, Lara, Mease, Philip, Orbai, Ana Maria, Shea, Beverley, Strand, Vibeke,...Ogdie, Alexis. (2019). Endorsement of the 66/68 joint count for the measurement of musculoskeletal disease activity: OmeRACT 2018 psoriatic arthritis workshop report. Journal of Rheumatology, 46(8), 996–1005. https://doi.org/10.3899/jrheum.181089
Eder, L., Haddad, A., Rosen, C. F., Lee, K.-A., Chandran, V., Cook, R., & Gladman, D. D. (2016). The incidence and risk factors for psoriatic arthritis in patients with psoriasis: A prospective cohort study. Arthritis & Rheumatology, 68(4), 915–923. https://doi.org/10.1002/art.39494
Eder, L., Polachek, A., Rosen, C. F., Chandran, V., Cook, R., & Gladman, D. D. (2017). The development of psoriatic arthritis in patients with psoriasis is preceded by a period of nonspecific musculoskeletal symptoms: A prospective cohort study. Arthritis & Rheumatology, 69(3), 622–629. https://doi.org/10.1002/art.39973
Gika, H., & Theodoridis, G. (2011). Sample preparation prior to the LC–MS-based metabolomics/metabonomics of blood-derived samples. Bioanalysis, 3(14), 1647–1661. https://doi.org/10.4155/bio.11.122
Gladman, D. D., Antoni, C., Mease, P., Clegg, D. O., & Nash, P. (2005). Psoriatic arthritis: Epidemiology, clinical features, course, and outcome. Annals of The Rheumatic Diseases, 64(suppl 2), 14–7. https://doi.org/10.1136/ard.2004.032482
Gladman, Dafna D., & Chandran, V. (2011). Observational cohort studies: Lessons learnt from the University of Toronto Psoriatic arthritis program. Rheumatology. https://doi.org/10.1093/rheumatology/keq262
Guma, M., Tiziani, S., & Firestein, G. S. (2016). Metabolomics in rheumatic diseases: Desperately seeking biomarkers. Nature Reviews Rheumatology. https://doi.org/10.1038/nrrheum.2016.1
Haroon, M., Gallagher, P., & FitzGerald, O. (2015). Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Annals of the Rheumatic Diseases, 74(6), 1045–1050. https://doi.org/10.1136/annrheumdis-2013-204858
Jiang, S., Hinchliffe, T. E., & Wu, T. (2015). Biomarkers of An Autoimmune Skin Disease—Psoriasis. Genomics, Proteomics & Bioinformatics, 13(4), 224–233. https://doi.org/10.1016/j.gpb.2015.04.002
Kamleh, M. A., Snowden, S. G., Grapov, D., Blackburn, G. J., Watson, D. G., Xu, N., Ståhle, Mona, & Wheelock, C. E. (2015). LC–MS Metabolomics of Psoriasis Patients Reveals Disease Severity-Dependent Increases in Circulating Amino Acids That Are Ameliorated by Anti-TNFα Treatment. Journal of Proteome Research, 14(1), 557–566. https://doi.org/10.1021/pr500782g
Kohler, I., Verhoeven, A., Derks, R. J., & Giera, M. (2016). Analytical pitfalls and challenges in clinical metabolomics. Bioanalysis, 8(14), 1509–1532. https://doi.org/10.4155/bio-2016-0090
Korman, S. H., Mandel, H., & Gutman, A. (2000). Characteristic urine organic acid profile in peroxisomal biogenesis disorders. Journal of Inherited Metabolic Disease, 23(4), 425–428. https://doi.org/10.1023/A:1005624523611
Li, L., Lu, C. J., Han, L., Deng, J. W., He, Z. H., Yan, Y. H., & Zhang, Z. Z. (2017). Untargeted serum metabonomics study of psoriasis vulgaris based on ultra-performance liquid chromatography coupled to mass spectrometry. Oncotarget. https://doi.org/10.18632/oncotarget.21562
Lowes, M. A., Bowcock, A. M., & Krueger, J. G. (2007). Pathogenesis and therapy of psoriasis. Nature, 2007(445), 7130.
Matsumoto, M., Kuhara, T., Inoue, Y., Shinka, T., & Matsumoto, I. (1991). Abnormal fatty acid metabolism in patients in hopantenate therapy during clinical episodes. Journal of Chromatography, 562(1–2), 139–145. https://doi.org/10.1016/0378-4347(91)80572-t
Miyazaki, I., & Asanuma, M. (2009). Approaches to prevent dopamine quinone-induced neurotoxicity. Neurochemical Research. https://doi.org/10.1007/s11064-008-9843-1
Monzani, E., Nicolis, S., Dell’Acqua, S., Capucciati, A., Bacchella, C., Zucca, F. A., Mosharov, E. V., Sulzer, David, Zecca, Luigi, & Casella, Luigi. (2019). Dopamine, oxidative stress and protein-quinone modifications in Parkinson’s and other neurodegenerative diseases. Angewandte Chemie—International Edition. https://doi.org/10.1002/anie.201811122
Muth, A., Jung, J., Bilke, S., Scharrer, A., Mosandl, A., Sewell, A. C., & Böhles, H. (2003). Simultaneous enantioselective analysis of chiral urinary metabolites in patients with Zellweger syndrome. Journal of chromatography. B, Analytical Technologies in The Biomedical and Life Sciences, 792(2), 269–77. https://doi.org/10.1016/s1570-0232(03)00285-x
Okajima, K., Asai, K., Niwa, T., Ohki, S., Sobajima, H., Tyson, J., Malcolm, Sue, & Wada, Yoshiro. (2002). Clinical and biochemical findings of a patient with thanatophoric dysplasia type I: Additional finding of dicarboxylic aciduria. The Cleft Palate-Craniofacial Journal, 39(2), 246–248. https://doi.org/10.1597/1545-1569_2002_039_0246_cabfoa_2.0.co_2
Ottas, A., Fishman, D., Okas, T.-L., Kingo, K., & Soomets, U. (2017). The metabolic analysis of psoriasis identifies the associated metabolites while providing computational models for the monitoring of the disease. Archives of Dermatological Research, 309(7), 519–528. https://doi.org/10.1007/s00403-017-1760-1
Petronic-Rosic, V., & Basko-Plluska, J. (2012). Psoriasis: epidemiology, natural history, and differential diagnosis. Psoriasis: Targets and Therapy, 2, 67. https://doi.org/10.2147/PTT.S24009
Rachakonda, T. D., Schupp, C. W., & Armstrong, A. W. (2014). Psoriasis prevalence among adults in the United States. Journal of the American Academy of Dermatology, 70(3), 512–516. https://doi.org/10.1016/J.JAAD.2013.11.013
Reyes-Garcés, N., Diwan, M., Boyacı, E., Gómez-Ríos, G. A., Bojko, B., Nobrega, J. N., Bambico, F. R., Hamani, Clement, & Pawliszyn, Janusz. (2019). In vivo brain sampling using a microextraction probe reveals metabolic changes in rodents after deep brain stimulation. Analytical Chemistry, 91(15), 9875–9884. https://doi.org/10.1021/acs.analchem.9b01540
Reyes-Garcés, N., & Gionfriddo, E. (2019). Recent developments and applications of solid phase microextraction as a sample preparation approach for mass-spectrometry-based metabolomics and lipidomics. TrAC—Trends in Analytical Chemistry. https://doi.org/10.1016/j.trac.2019.01.009
Reyes-Garcés, N., Gionfriddo, E., Gómez-Ríos, G. A., Alam, M. N., Boyacı, E., Bojko, B., Singh, Varoon, Grandy, Jonathan, & Pawliszyn, Janusz. (2018). Advances in solid phase microextraction and perspective on future directions. Analytical Chemistry, 90(1), 302–360. https://doi.org/10.1021/acs.analchem.7b04502
Souza-Silva, É. A., Reyes-Garcés, N., Gómez-Ríos, G. A., Boyaci, E., Bojko, B., & Pawliszyn, J. (2015). A critical review of the state of the art of solid-phase microextraction of complex matrices iii. bioanalytical and clinical applications. TrAC Trends in Analytical Chemistry. https://doi.org/10.1016/j.trac.2015.04.017
Vuckovic, D. (2012). Current trends and challenges in sample preparation for global metabolomics using liquid chromatography-mass spectrometry. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-012-6039-y
Vuckovic, D., & Pawliszyn, J. (2011). Systematic evaluation of solid-phase microextraction coatings for untargeted metabolomic profiling of biological fluids by liquid chromatography-mass spectrometry. Analytical Chemistry, 83, 1944–1954. https://doi.org/10.1021/ac102614v
Yan, D., Afifi, L., Jeon, C., Trivedi, M., Chang, H. W., Lee, K., & Liao, W. (2017). The metabolomics of psoriatic disease. Psoriasis: Targets and Therapy, 7, 1–15. https://doi.org/10.2147/PTT.S118348
Yan, J. (2017). Identifying biomarkers in human psoriasis: Revealed by a systems metabolomics approach. British Journal of Dermatology, 176(3), 555–557. https://doi.org/10.1111/bjd.15249